MedPath

Assessment effect of suppository of a drug based on Percian medicine on bacterial vaginosis

Phase 1
Conditions
bacterial vaginosis.
Acute vaginitisinitis
Registration Number
IRCT2016062528613N1
Lead Sponsor
Tehran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

Outpatient women aged 18- 50 years with symptoms such as burning and itching refer and amsel criteria for bacterial vaginosis is positive for them; that Both treatments (chemical or herbal) do not use;They do not suffer from organic diseases such as cancer or other malignancies of the uterus or ovaries or Patients with chronic diseases. Exclusion criteria: Patients who use other antibiotics during the study; Patients who are experiencing possible side effect; Patients who have other medical interventions needed;This group of patients who have a severe form of the disease and other therapies and may require hospitalization have been included; Patients who request personal decision to withdraw from the study; Patients with immunosuppressive disorders; people with HIV; Patients with other infections such as genital herpes or trichomoniasis or fungal or gonorrhea at the same time with bacterial vaginosis; People who take other medication Such as the use of immunosuppressive drug or consumers of anti-inflammatory;consumers of showers vaginal and vaginal acidifying agents

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amsel criteria. Timepoint: Before the intervention,10-14 days after begining of treatment. Method of measurement: Amsel have 4 criteria: key cells in the wet mount vaginal sample Vaginal dyscharge thin and white uniform - gray, white or yellowish, Vaginal pH equal to or greater than 4/5, positive whiff test. If at least 3 of the 4 cases mentioned above is positive, bacterial vaginosis is brought on .;Clinical signs for example Malodorous discharge, Itching, dyspareunia, having bad smell during sexual intercourse. Timepoint: Before the intervention, 10-14 day after intervention. Method of measurement: Measured by asking from patient.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: Within 10 to 14 days of intervention. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath